Skip to content

Study on ImP level of coronary heart disease patients with diabetes mellitus

Study on ImP level of coronary heart disease patients with diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084255
Enrollment
Unknown
Registered
2024-05-13
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

Diabetes mellitus+coronary heart disease:None
None Diabetes mellitus+coronary heart disease:None
Diabetes mellitus+ None coronary heart disease:None
None Diabetes mellitus+ None coronary heart disease:None

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the corresponding diagnostic criteria: ? The DCHD group met the diagnostic criteria for both diabetes and CHD; ? the NDCHD group met the diagnostic criteria for CHD but not diabetes; ? the DM group met the diagnostic criteria for diabetes but not CHD; ? the Control group did not meet the diagnostic criteria for diabetes and CHD. (2) Age between 18 and 75 years old, gender is not limited; (3) Voluntarily participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Combined with congenital heart disease, severe cardiac insufficiency (heart function grade III or above), acute cerebrovascular disease; (2) Combined with acute and chronic infections, liver and renal insufficiency or other immune, ematopoietic system and other serious primary diseases; (3) History of malignant tumor; (4) Combined with mental illness, severe neurosis; (5) Those who have used antibiotics, prebiotics or probiotic products within 2 weeks.

Design outcomes

Primary

MeasureTime frame
Targeted identification of ImP levels and ImP precursor antiurinary acid levels in peripheral blood;

Secondary

MeasureTime frame
blood routine; blood biochemistry;glycosylated hemoglobin;myocardial injury markers;cardiac function indicators;inflammatory factors;

Countries

China

Contacts

Public ContactYue Liu

Xiyuan Hospital, China Academy of Chinese Medical Sciences

liuyue@188.com+86 137 0116 7815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026